MarginsXMarginsX
Home › Markets › Industrials › WAT

Waters Corporation (WAT)

WAT trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$453.42
-1.48% on the day
Market cap
$44.6B
Large cap
Revenue · 2025
$3.2B
+7.0% on 2024
Net income · 2025
$642.6M
20.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/0001193125-26-062604-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerWAT on NYSE
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year1995
SEC CIK0001000697
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.2B
Net income$642.6M
Operating income$802.6M
Net margin20.3%
Operating margin25.4%
Revenue growth+7.0%
Cash$587.8M
Total assets$5.1B
P/E (computed)69.3×
P/S (computed)14.1×

Warning signs

Cash runway
Cash-flow positive
$593.0M cash at October 3, 2026
Share count, 1 year
+65.1%
2025-10-31 to 2026-11-06 · +66.2% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$992K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$593.0M cash; operating cash flow $119.9M a quarter.Report 2026-10-03
Shares outstanding98,285,634 (2026-11-06); 59,534,740 a year earlier; 59,126,977 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-16
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $451K, sold $1.4M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-10-03
$1.8B$81.0M$117.0M$593.0M$4.5B$5.6B10-Q 2026-11-10
Q2 2026
2026-07-04
$1.6B-$136.0M$201.0M$539.0M$4.9B$4.6B10-Q 2026-08-11
Q1 2026
2026-04-04
$1.3B-$72.0M-$3.0M$462.0M$4.9BNeeds four quarters10-Q 2026-05-12
Q4 2025
2025-12-31
$932.4M$225.6M$164.6M$588.0M$1.4B$3.2B10-K 2026-02-23
Q3 2025
2025-09-30
$799.9M$148.9MNot filed$459.1M$947.2MNeeds four quarters10-K 2026-02-23
Q3 2025
2025-09-27
$800.0M$149.0M$187.0M$459.1M$947.2MNeeds four quarters10-Q 2026-11-10
Q2 2025
2025-06-30
$771.3M$147.1MNot filed$367.2M$1.2BNeeds four quarters10-K 2026-02-23
Q2 2025
2025-06-28
$771.0M$147.0M$41.0M$367.2M$1.2BNeeds four quarters10-Q 2026-08-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-03-19
Latest annual report10-K2026-02-23
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-03
Latest proxyDEFA14A2026-04-09

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.6%
1 month+7.2%
3 months+11.3%
Year to date+21.2%
1 year+21.3%
From 52-week high-4.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
AAgilent Technologies Inc.$172.92-0.60%$48.8B
MTDMettler-Toledo International Inc.$1727.26-0.67%$34.4B
RVTYRevvity Inc.$148.85-3.59%$16.6B
AVTRAvantor Inc.$15.32-1.42%$10.4B
BIOBio-Rad Laboratories Inc.$360.26-1.67%$9.7B
BRKRBruker Corporation$60.62-1.57%$9.3B
TXG10x Genomics Inc.$54.99-5.50%$7.2B
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier